Loading…
The m6A epitranscriptome on neural development and degeneration
N 6 -methyladenosine (m 6 A) is the most prevalent, conserved, and abundant RNA modification of the mRNAs of most eukaryotes, including mammals. Similar to epigenetic DNA modifications, m 6 A has been proposed to function as a critical regulator for gene expression. This modification is installed by...
Saved in:
Published in: | Journal of biomedical science 2021-05, Vol.28 (1), p.1-40, Article 40 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | N
6
-methyladenosine (m
6
A) is the most prevalent, conserved, and abundant RNA modification of the mRNAs of most eukaryotes, including mammals. Similar to epigenetic DNA modifications, m
6
A has been proposed to function as a critical regulator for gene expression. This modification is installed by m
6
A methylation “writers” (Mettl3/Mettl14 methyltransferase complex), and it can be reversed by demethylase “erasers” (Fto and Alkbh5). Furthermore, m
6
A can be recognized by “readers” (Ythdf and Ythdc families), which may be interpreted to affect mRNA splicing, stability, translation or localization. Levels of m
6
A methylation appear to be highest in the brain, where it plays important functions during embryonic stem cell differentiation, brain development, and neurodevelopmental disorders. Depletion of the m
6
A methylation writer
Mettl14
from mouse embryonic nervous systems prolongs cell cycle progression of radial glia and extends cortical neurogenesis into postnatal stages. Recent studies further imply that dysregulated m
6
A methylation may be significantly correlated with neurodegenerative diseases. In this review, we give an overview of m
6
A modifications during neural development and associated disorders, and provide perspectives for studying m
6
A methylation. |
---|---|
ISSN: | 1423-0127 1021-7770 1423-0127 |
DOI: | 10.1186/s12929-021-00734-6 |